Skip to content

First Level Socio-geriatric Evaluation: ESOGER Databank

First Level Socio-geriatric Evaluation in Period of Physical and Social Distancing in Frail Older Patients and Older Community Dwellers: ESOGER Databank

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04393649
Enrollment
20000
Registered
2020-05-19
Start date
2020-04-20
Completion date
2027-04-19
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, COVID, Frailty, Social Isolation

Brief summary

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER (Evaluation Social et GERiatrique) is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Interventions

OTHERESOGER

Questionnaire

Sponsors

Jewish General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum

Inclusion criteria

The inclusion criteria are: 1. Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria 2. Living and staying at home because of physical and social distancing 3. Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.) 4. Agree to participate in the study The

Exclusion criteria

are: 1. A concomitant participation to another medical trial 2. Living in semi-autonomous residence or CHSLD

Design outcomes

Primary

MeasureTime frameDescription
psychological frailty1 dayanxiety Verbal analogic scale, score from 0 = no anxiety to 10 = extremely anxious)
COVID-19 symptoms1 daypresence or not of fever, cough and shortness of breath (binary question)
issues related to medication and food delivery and access to home care1 daypresence or not of a rupture of access to food, medication and home care (binary question)
physical frailty1 dayQuestionnaire Emergency Room Evaluation and Recommandation (ER2), score from 0 = no risk of frailty to 14 = high risk of frailty)

Secondary

MeasureTime frameDescription
Caregiver burden1 dayZarit scale, score from 0 = no caregiver burden to 16 = high caregiver burden)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026